Anuh Pharma Ltd receives EDQM approval for CEP of Sulfadoxine API

Anuh Pharma Ltd. has received approval from EDQM for CEP of Sulfadoxine API which is a AntiMalarial Drug.

Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 212.45 as compared to the previous close of Rs. 216.80. The total number of shares traded during the day was 61069 in over 1161 trades.

The stock hit an intraday high of Rs. 218.55 and intraday low of 210.60. The net turnover during the day was Rs. 13097206.00.

Source : Equity Bulls

Keywords

ANUHPHARMA INE489G01022 EDQMApproval CEP SulfadoxineAPI AntiMalarialDrug